Loading compound...

Small molecule

Rigosertib Sodium is a small molecule drug currently being studied in clinical trials. It is being investigated for various types of blood cancers and other neoplasms.

Used for
Refractory anemia with excess blastsChronic myelomonocytic leukemiaOvarian cancerAcute myeloid leukemiaMyelodysplastic syndromeChronic lymphocytic leukemiaChronic myelogenous leukemiaVarious neoplasms
Conditions
Refractory anemia with excess blastsChronic myelomonocytic leukemiaOvarian cancerAcute myeloid leukemiaMyelodysplastic syndromeChronic lymphocytic leukemiaChronic myelogenous leukemiaNeoplasm
Class
Small moleculeHematologic

How to take

This drug is currently in clinical development phases (up to Phase 3) and is not yet a standard approved treatment for these conditions in the provided data.

Talk to your doctor

Questions to ask

  • ·Is Rigosertib Sodium appropriate for my type of leukemia?
  • ·What stage of clinical trials is Rigosertib Sodium currently in?
  • ·Are there specific side effects I should watch for with Rigosertib Sodium?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.